Back
Cartesian Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
40
RNAC
Cartesian Therapeutics
Last Price:
$13.12
Seasonality Move:
-1.08%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing slight buying pressure.
Cartesian Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.02 | Buy |
| 20-day SMA: | 11.01 | Buy |
| 50-day SMA: | 10.59 | Buy |
| 200-day SMA: | 16.11 | Sell |
| 8-day EMA: | 8.33 | Buy |
| 20-day EMA: | 4.31 | Buy |
| 50-day EMA: | 1.92 | Buy |
| 200-day EMA: | 0.51 | Buy |
Cartesian Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.93 | Buy |
| Relative Strength Index (14 RSI): | 65.92 | Buy |
| Chaikin Money Flow: | 13200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.79 - 12.01) | Buy |
| Bollinger Bands (100): | (9.51 - 15.85) | Buy |
Cartesian Therapeutics Technical Analysis
| Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 13.32 while RNAC 8-day simple moving average is 12.02, which is a Buy signal.
-
The stock price of RNAC is 13.32 while Cartesian Therapeutics 20-day SMA is 11.01, which makes it a Buy.
-
Cartesian Therapeutics 50-day simple moving average is 10.59 while RNAC share price is 13.32, making it a Buy technically.
-
RNAC stock price is 13.32 and Cartesian Therapeutics 200-day simple moving average is 16.11, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
40
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a SellThe current Cartesian Therapeutics [RNAC] share price is $13.32. The Score for RNAC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
345.7M
Price in USD:
13.32
Share Volume:
54.1K
Cartesian Therapeutics 52-Week Range
52-Week High:
26.50
52-Week Low:
8.46
Sell
40
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?The Cartesian Therapeutics stock price is 13.32 USD today.
-
Will RNAC stock go up or go down?Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cartesian Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 13.32 while RNAC 8-day exponential moving average is 8.33, which is a Buy signal.
-
The stock price of RNAC is 13.32 while Cartesian Therapeutics 20-day EMA is 4.31, which makes it a Buy.
-
Cartesian Therapeutics 50-day exponential moving average is 1.92 while RNAC share price is 13.32, making it a Buy technically.
-
RNAC stock price is 13.32 and Cartesian Therapeutics 200-day simple moving average is 0.51, creating a Buy signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.83 per share, and an increase next year of $0.35 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
-
RNAC Moving Average Covergence Divergence (MACD) indicator is 2.93, suggesting Cartesian Therapeutics is a Buy
-
Cartesian Therapeutics Relative Strength Index (RSI) is 65.92, which suggest Cartesian Therapeutics is overbought
-
The Bollinger Bands (25) for Cartesian Therapeutics is (9.79 - 12.01), which suggest Cartesian Therapeutics is a Buy
-
The Bollinger Bands (100) for Cartesian Therapeutics is (9.51 - 15.85), which suggest Cartesian Therapeutics is a Buy
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.